Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

6.620 -0.140 (-2.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 300,351
Open 6.730
Bid (Size) 6.500 (7)
Ask (Size) 7.170 (5)
Prev. Close 6.760
Today's Range 6.600 - 6.940
52wk Range 3.920 - 11.95
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Rosen Law Firm Urges Treace Medical Concepts, Inc. (NASDAQ: TMCI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical
From Faruqi & Faruqi LLP
Via GlobeNewswire

Performance

YTD
-15.9%
-15.9%
1 Month
-16.9%
-16.9%
3 Month
-20.8%
-20.8%
6 Month
+27.3%
+27.3%
1 Year
-44.3%
-44.3%

More News

Read More
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Treace Announces Upcoming Board Chair Transition
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Get insights into the top gainers and losers of Friday's pre-market session.
Via Chartmill
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2024 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Why Pinterest Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces First Surgical Cases Utilizing the SpeedAkin™ Anatomic Compression Implant
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue
From Treace Medical Concepts, Inc.
Via GlobeNewswire
The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
This Vertex Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Tuesday
Via Benzinga
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm
Via ACCESSWIRE
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
From Treace Medical Concepts, Inc.
Via GlobeNewswire
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Treace Medical Concepts, Inc. For Securities Fraud
Via ACCESSWIRE
Treace Medical Concepts Inc Is Being Investigated For Securities Law Violations And Investors With Losses Are Invited To Contact The Schall Law Firm
Via ACCESSWIRE

Frequently Asked Questions

Is Treace Medical Concepts, Inc. - Common Stock publicly traded?
Yes, Treace Medical Concepts, Inc. - Common Stock is publicly traded.
What exchange does Treace Medical Concepts, Inc. - Common Stock trade on?
Treace Medical Concepts, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Treace Medical Concepts, Inc. - Common Stock?
The ticker symbol for Treace Medical Concepts, Inc. - Common Stock is TMCI on the Nasdaq Stock Market
What is the current price of Treace Medical Concepts, Inc. - Common Stock?
The current price of Treace Medical Concepts, Inc. - Common Stock is 6.620
When was Treace Medical Concepts, Inc. - Common Stock last traded?
The last trade of Treace Medical Concepts, Inc. - Common Stock was at 04/15/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.